Cabazitaxel-loaded redox-responsive nanocarrier based on <scp>d</scp>-alpha-tocopheryl-chitosan and hyaluronic acid for improved anti-tumor efficacy in DMBA-induced breast cancer model-Reference-Cited by-同舟云学术

Cabazitaxel-loaded redox-responsive nanocarrier based on d-alpha-tocopheryl-chitosan and hyaluronic acid for improved anti-tumor efficacy in DMBA-induced breast cancer model

Published:2024 Issue: Volume: Page:
ISSN:2633-5409
Container-title:Materials Advances
language:en
Short-container-title:Mater. Adv.

Author:

Jha Abhishek¹^ORCID,Kumar Manish¹^ORCID,Goswami Pooja²^ORCID,Bharti Kanchan¹^ORCID,Manjit Manjit¹^ORCID,Gupta Ashutosh³^ORCID,Moorkoth Sudheer³^ORCID,Koch Biplob²^ORCID,Mishra Brahmeshwar¹^ORCID

Affiliation:

1. Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (BHU), Varanasi - 221005, Uttar Pradesh, India

2. Genotoxicology and Cancer Biology Laboratory, Department of Zoology Institute of Science, Banaras Hindu University, Varanasi - 221005, Uttar Pradesh, India

3. Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal - 576104, Karnataka, India

Abstract

The study involved the formulation and evaluation of cabazitaxel loaded d-alpha-tocopheryl succinate/chitosan conjugate (CSVE) and hyaluronic acid (HA) based redox-responsive nanoparticle crosslinked using 3,3′-dithiodipropionic acid (DTPA).

Funder

Banaras Hindu University

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/MA/D4MA00556B

Reference85 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Targeted drug delivery strategies for precision medicines

3. Engineering precision nanoparticles for drug delivery

4. Nanomedicine in cancer therapy

5. Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles